Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2019 · 10-Q
Revenue$124.67M$124.67M+7.7% vs Q1 2018 Net Income$190.00K$190.00K−91.1% vs Q1 2018 EPS Diluted$0.01$0.01−87.5% vs Q1 2018 Gross Profit$16,337,000−13.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$2,186,000−36.6% Free Cash Flowderived-$12,254,000N/M Margins · derivedGross margin13.1%−3.1 pt vs Q1 2018
Operating margin-0.2%−2.6 pt vs Q1 2018
Net margin0.2%−1.7 pt vs Q1 2018
ended Aug 26, 2018 · filed Oct 5, 2018 · 40 d after period end